185 related articles for article (PubMed ID: 1409722)
21. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
Rao E; Dang W; Tian G; Sen R
J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
[TBL] [Abstract][Full Text] [Related]
22. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
[TBL] [Abstract][Full Text] [Related]
23. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.
Grant PA; Thompson CB; Pettersson S
EMBO J; 1995 Sep; 14(18):4501-13. PubMed ID: 7556093
[TBL] [Abstract][Full Text] [Related]
24. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors.
Hernandez-Munain C; Krangel MS
Mol Cell Biol; 1994 Jan; 14(1):473-83. PubMed ID: 8264615
[TBL] [Abstract][Full Text] [Related]
26. Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein.
Woods DB; Ghysdael J; Owen MJ
Nucleic Acids Res; 1992 Feb; 20(4):699-704. PubMed ID: 1542566
[TBL] [Abstract][Full Text] [Related]
27. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.
Henkel G; Brown MA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7737-41. PubMed ID: 8052653
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like site.
Martin CB; Martin BK
J Immunol; 2005 Sep; 175(5):3123-32. PubMed ID: 16116202
[TBL] [Abstract][Full Text] [Related]
29. Activity of both Raf and Ras is necessary for activation of transcription of the human T cell receptor beta gene by protein kinase C, Ras plays multiple roles.
Wotton D; Ways DK; Parker PJ; Owen MJ
J Biol Chem; 1993 Aug; 268(24):17975-82. PubMed ID: 8349679
[TBL] [Abstract][Full Text] [Related]
30. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
31. One of two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins.
Fujimura Y; Yamamoto H; Hamazato F; Nozaki M
Nucleic Acids Res; 1994 Feb; 22(4):613-8. PubMed ID: 7510396
[TBL] [Abstract][Full Text] [Related]
32. Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.
Sieweke MH; Tekotte H; Jarosch U; Graf T
EMBO J; 1998 Mar; 17(6):1728-39. PubMed ID: 9501094
[TBL] [Abstract][Full Text] [Related]
33. Regulation of AP-3 enhancer activity during hematopoietic differentiation.
Adler V; Kraft AS
J Cell Physiol; 1995 Jul; 164(1):26-34. PubMed ID: 7790394
[TBL] [Abstract][Full Text] [Related]
34. An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites.
Reddy MA; Langer SJ; Colman MS; Ostrowski MC
Mol Endocrinol; 1992 Jul; 6(7):1051-60. PubMed ID: 1324418
[TBL] [Abstract][Full Text] [Related]
35. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
[TBL] [Abstract][Full Text] [Related]
36. Precise alignment of sites required for mu enhancer activation in B cells.
Nikolajczyk BS; Nelsen B; Sen R
Mol Cell Biol; 1996 Aug; 16(8):4544-54. PubMed ID: 8754855
[TBL] [Abstract][Full Text] [Related]
37. Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
Erman B; Sen R
EMBO J; 1996 Sep; 15(17):4665-75. PubMed ID: 8887557
[TBL] [Abstract][Full Text] [Related]
38. Evolutionarily conserved Ets family members display distinct DNA binding specificities.
Wang CY; Petryniak B; Ho IC; Thompson CB; Leiden JM
J Exp Med; 1992 May; 175(5):1391-9. PubMed ID: 1569404
[TBL] [Abstract][Full Text] [Related]
39. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
40. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.
McNagny KM; Sieweke MH; Döderlein G; Graf T; Nerlov C
EMBO J; 1998 Jul; 17(13):3669-80. PubMed ID: 9649437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
